Comparative Effectiveness of Dapagliflozin Versus DPP-4 Inhibitors

NCT04304430 · clinicaltrials.gov ↗

COMPLETED

Status

11206

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Dapagliflozin
DRUG: DPP-4 inhibitor

Sponsor

University of Padova